Vertebral Fractures in Boys with Duchenne Muscular Dystrophy-Reference-Cited by-同舟云学术

Vertebral Fractures in Boys with Duchenne Muscular Dystrophy

Published:2003-05 Issue:4 Volume:42 Page:353-356
ISSN:0009-9228
Container-title:Clinical Pediatrics
language:en
Short-container-title:Clin Pediatr (Phila)

Author:

Bothwell J. E.¹,Gordon K. E.,Dooley J. M.,Mac Sween J.²,Cummings E. A.,Salisbury S.³

Affiliation:

1. Royal Belfast Hospital for Sick Children, Northern Ireland

2. Division of Pediatric Neurology; Pediatric Endocrinology, IWK Health Centre, Nova Scotia, Canada

3. Division of Pediatric Endocrinology, IWK Health Centre, Nova Scotia, Canada

Abstract

Osteoporosis causes significant morbidity for boys with Duchenne muscular dystrophy. Corticosteroid therapy given to prolong mobility may increase the rate of osteoporosis and risk of fracture. This study of 33 boys with Duchenne muscular dystrophy determined retrospectively the incidence of vertebral fractures particularly after initiation of corticosteroids. A latency period of 40 months after commencement of steroids occurred before the first vertebral fracture appeared. However, by 100 months of treatment approximately 75% had sustained a vertebral fracture.

Publisher

SAGE Publications

Subject

Pediatrics, Perinatology and Child Health

Link

http://journals.sagepub.com/doi/pdf/10.1177/000992280304200408

Reference12 articles.

1. Duchenne Muscular Dystrophy

2. Duchenne muscular dystrophy: Patterns of clinical progression and effects of supportive therapy

3. Prednisone Treatment in Duchenne Muscular Dystrophy

4. Deflazacort in Duchenne dystrophy: Study of long-term effect

5. Deflazacort treatment of Duchenne muscular dystrophy

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is endocrine surveillance important in the care of Duchenne Muscular Dystrophy? Results from a national survey to patients and families on endocrine complications;eNeurologicalSci;2024-09

2. The Use of a Virtual Reality System in the Rehabilitation of Children with Progressive Muscular Dystrophies;Revista de la Universidad del Zulia;2024-05-02

3. Spine health: Back pain and deformity progression;Journal of the Pediatric Orthopaedic Society of North America;2024-05

4. Bisphosphonates in Glucocorticoid-Treated Patients With Duchenne Muscular Dystrophy;Neurology;2024-01-23

5. Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022;Journal of Neuromuscular Diseases;2024-01-02